KR830001273A - 할로겐 치환된 벤조피란-및 벤조티오피란-4-카복실산 - Google Patents
할로겐 치환된 벤조피란-및 벤조티오피란-4-카복실산 Download PDFInfo
- Publication number
- KR830001273A KR830001273A KR1019790003889A KR790003889A KR830001273A KR 830001273 A KR830001273 A KR 830001273A KR 1019790003889 A KR1019790003889 A KR 1019790003889A KR 790003889 A KR790003889 A KR 790003889A KR 830001273 A KR830001273 A KR 830001273A
- Authority
- KR
- South Korea
- Prior art keywords
- structural formula
- fluoro
- chloro
- sulfur
- compound
- Prior art date
Links
- SDPKJLZZXXJECC-UHFFFAOYSA-N C1=CC=C2C=CCOC2=C1.C1=CC=C2C(C(=O)O)=CCSC2=C1 Chemical class C1=CC=C2C=CCOC2=C1.C1=CC=C2C(C(=O)O)=CCSC2=C1 SDPKJLZZXXJECC-UHFFFAOYSA-N 0.000 title 1
- 229910052736 halogen Inorganic materials 0.000 title 1
- 125000005843 halogen group Chemical group 0.000 title 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 6
- 125000001309 chloro group Chemical group Cl* 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 125000001153 fluoro group Chemical group F* 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 239000011593 sulfur Substances 0.000 claims 6
- 239000002253 acid Substances 0.000 claims 5
- 125000001246 bromo group Chemical group Br* 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 239000001257 hydrogen Substances 0.000 claims 5
- 125000000217 alkyl group Chemical group 0.000 claims 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 239000001301 oxygen Substances 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 239000004575 stone Substances 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 150000004820 halides Chemical class 0.000 claims 2
- 229910000510 noble metal Inorganic materials 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- XTQHKBHJIVJGKJ-UHFFFAOYSA-N sulfur monoxide Chemical group S=O XTQHKBHJIVJGKJ-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 229960000583 acetic acid Drugs 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000012362 glacial acetic acid Substances 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229910052763 palladium Inorganic materials 0.000 claims 1
- 238000006722 reduction reaction Methods 0.000 claims 1
- 230000002829 reductive effect Effects 0.000 claims 1
- 238000010992 reflux Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (8)
- 구조식(a)의 화합물을 산용액중에서 제1석 할라이드로 환원적 가수분해시키고, 구조식 (A) 중 X가 S=O또는가 될때는 X가 유황인 구조식(A)의 상응한 화합물을 산화시키며, 원한다면 구조식 A의 산을 C1-C4알킬에스테르 또는 약제학적으로 허용되는 염으로 전환시킴으로써 구조식(A)의 화합물을 제조하는 방법.상기 구조식 중 X가 산소, 유황,S=O또는일때 R1은 수소, 클로로, 브로모, 플루오로 또는 페닐이고; R2및 R3는 각기 수소, 탄소수 1-3개의 알킬, 클로로, 블로모 또는 플루오로이다. 합해서 생각하면 R2, R3및 이들이 연결된 탄소원자는 융합된 벤젠환을 형성한다. 단 R1, R2및 R3중 적어도 한개는 클로로, 브로모 및 플루오로로 구성되는 그룹중에서 선택된다.상기 구조식중 R'는 탄소수 1-4개의 알킬이고 Y는 산소 또는 유황이다.
- 특허청구의 범위 1중 제1석 할라이드가 제1석 클로라이드인 특허청구 범위 1에 따르는 방법.
- 특허청구의 범위 1중 온도가 100℃ -200℃ 인 특허청구 범위 1에 따르는 방법.
- 특허청구 범위 2중 반응이 빙초산과 염산 혼합물중 환류온도에서 시행되는 특허청구 범위 2에 따르는 방법.
- 구조식(b)의 화합물을 환원시키고, 구조식(B)중 X가 S=O 또는가 될때는 X가 유황인 구조식(B)의 상응한 화합물을 산화시키며, 원한다면 구조식(B)의 에스테르를 상응하는 산으로 가수분해하고, 원한다면 언급된 산을 약제학적으로 허용되는 염으로 전환시킴으로써 구조식(B)의 화합물을 제조하는 방법.상기 구조식중 X는 산소, 유황, S=O 또는이고; R은 탄소수 1-4개의 알킬; R1은 수소, 클로로, 브로모, 플루오로 또는 페닐이며; R2및 R3는 각기 수소, 탄소수 1-3개의 알킬, 클로로, 브로모 또는 플루오로이고; 합해서 생각하면 R2, R3및 이들이 연결된 탄소원자가 융합된 벤젠환을 형성한다; 단 R1, R2및 R3중 적어도 하나는 클로로, 브로모 및 플루오로로 구성되는 그룹중에서 선택된다.상기 구조식중 Y는 산소 또는 유황이다.
- 특허청구 범위 5중 환원 반응이 귀금속 촉매 존재시 수소에 의해 일어나는 특허청구 범위 5에 따르는 방법.
- 특허청구 범위 6중 귀금속이 팔라듐인 특허청구 범위 6에 따르는 방법.
- 특허청구 범위 6중 구조식 B의 에스테르가 염기 존재시 가수분해되어 상응한 산으로 전환되는 특허청구 범위 6에 따르는 방법.※ 참고사항 :최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/959,023 US4210663A (en) | 1978-11-08 | 1978-11-08 | Halogen substituted benzopyran- and benzothiopyran-4-carboxylic acids |
| US959023 | 1978-11-08 | ||
| US959,023 | 1992-10-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR830001273A true KR830001273A (ko) | 1983-04-30 |
| KR830001821B1 KR830001821B1 (ko) | 1983-09-12 |
Family
ID=25501572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019790003889A KR830001821B1 (ko) | 1978-11-08 | 1979-11-07 | 할로겐 치환된 벤조피란 및 벤조 티오피란 4 카복실산의 제조방법 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4210663A (ko) |
| EP (1) | EP0011426B1 (ko) |
| JP (2) | JPS6033433B2 (ko) |
| KR (1) | KR830001821B1 (ko) |
| AR (1) | AR223195A1 (ko) |
| AT (1) | AT366680B (ko) |
| AU (1) | AU513399B2 (ko) |
| CA (1) | CA1132584A (ko) |
| DE (1) | DE2965755D1 (ko) |
| DK (1) | DK153947C (ko) |
| ES (1) | ES485798A1 (ko) |
| FI (1) | FI71139C (ko) |
| IE (1) | IE49109B1 (ko) |
| IL (1) | IL58656A (ko) |
| PT (1) | PT70420A (ko) |
| YU (1) | YU41675B (ko) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4305955A (en) * | 1980-10-21 | 1981-12-15 | Pfizer Inc. | Carboxylic acid therapeutic agents |
| US4486428A (en) * | 1982-03-16 | 1984-12-04 | Pfizer Inc. | Bicyclic benzo fused compounds |
| US4537920A (en) * | 1983-08-18 | 1985-08-27 | Ethyl Corporation | 4H-1-benzopyrans and lubricant compositions containing same |
| US4551542A (en) * | 1984-09-26 | 1985-11-05 | Pfizer Inc. | Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid |
| HU206618B (en) * | 1986-01-17 | 1992-12-28 | Pfizer | Process for producing hydroxyacetic acid derivatives for treating complications of diabetes and pharmaceutical compositions containing them |
| DE3737195A1 (de) * | 1987-11-03 | 1989-05-18 | Bayer Ag | Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| US5039672A (en) * | 1990-04-05 | 1991-08-13 | Pfizer Inc. | Heterocyclic compounds as aldose reductase inhibitors |
| EP0541807B1 (en) * | 1990-07-27 | 1997-12-17 | Chugai Seiyaku Kabushiki Kaisha | Novel benzopyran derivative |
| JP3255411B2 (ja) * | 1991-02-18 | 2002-02-12 | 中外製薬株式会社 | 発毛促進剤 |
| US5407897A (en) * | 1993-03-03 | 1995-04-18 | American Cyanamid Company | Method for safening herbicides in crops using substituted benzopyran and tetrahydronaphthalene compounds |
| AU2440599A (en) * | 1998-02-25 | 1999-09-15 | Shionogi & Co., Ltd. | Therapeutic agent for complication of diabetes |
| US7288279B2 (en) * | 2001-12-21 | 2007-10-30 | Michael Foods Of Delaware, Inc. | Formulated fried egg product |
| JP4742215B2 (ja) * | 2003-06-23 | 2011-08-10 | Ｊｎｃ株式会社 | クロマン化合物、この化合物を含有する液晶組成物およびこの液晶組成物を含有する液晶表示素子 |
| JP5956920B2 (ja) | 2012-12-14 | 2016-07-27 | 株式会社コガネイ | 液体供給装置 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
-
1978
- 1978-11-08 US US05/959,023 patent/US4210663A/en not_active Expired - Lifetime
-
1979
- 1979-11-05 YU YU2697/79A patent/YU41675B/xx unknown
- 1979-11-06 CA CA339,283A patent/CA1132584A/en not_active Expired
- 1979-11-06 DE DE7979302467T patent/DE2965755D1/de not_active Expired
- 1979-11-06 AR AR278784A patent/AR223195A1/es active
- 1979-11-06 EP EP79302467A patent/EP0011426B1/en not_active Expired
- 1979-11-07 AU AU52582/79A patent/AU513399B2/en not_active Ceased
- 1979-11-07 ES ES485798A patent/ES485798A1/es not_active Expired
- 1979-11-07 JP JP54144280A patent/JPS6033433B2/ja not_active Expired
- 1979-11-07 IL IL58656A patent/IL58656A/xx unknown
- 1979-11-07 PT PT70420A patent/PT70420A/pt unknown
- 1979-11-07 FI FI793487A patent/FI71139C/fi not_active IP Right Cessation
- 1979-11-07 DK DK471079A patent/DK153947C/da not_active IP Right Cessation
- 1979-11-07 IE IE2136/79A patent/IE49109B1/en unknown
- 1979-11-07 KR KR1019790003889A patent/KR830001821B1/ko active IP Right Grant
- 1979-11-08 AT AT0719279A patent/AT366680B/de not_active IP Right Cessation
-
1980
- 1980-12-15 JP JP17706780A patent/JPS56103176A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5585582A (en) | 1980-06-27 |
| US4210663A (en) | 1980-07-01 |
| DK153947B (da) | 1988-09-26 |
| FI71139B (fi) | 1986-08-14 |
| IE49109B1 (en) | 1985-08-07 |
| EP0011426A1 (en) | 1980-05-28 |
| ES485798A1 (es) | 1980-10-01 |
| FI71139C (fi) | 1986-11-24 |
| JPS6033433B2 (ja) | 1985-08-02 |
| DK153947C (da) | 1989-02-20 |
| CA1132584A (en) | 1982-09-28 |
| IL58656A0 (en) | 1980-02-29 |
| EP0011426B1 (en) | 1983-06-22 |
| IE792136L (en) | 1980-05-08 |
| FI793487A (fi) | 1980-05-09 |
| AU5258279A (en) | 1980-05-15 |
| YU41675B (en) | 1987-12-31 |
| KR830001821B1 (ko) | 1983-09-12 |
| JPS56103176A (en) | 1981-08-18 |
| IL58656A (en) | 1983-06-15 |
| AU513399B2 (en) | 1980-11-27 |
| ATA719279A (de) | 1981-09-15 |
| PT70420A (de) | 1979-12-01 |
| AR223195A1 (es) | 1981-07-31 |
| JPS6113716B2 (ko) | 1986-04-15 |
| DE2965755D1 (en) | 1983-07-28 |
| DK471079A (da) | 1980-05-09 |
| AT366680B (de) | 1982-04-26 |
| YU269779A (en) | 1983-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR830001273A (ko) | 할로겐 치환된 벤조피란-및 벤조티오피란-4-카복실산 | |
| ATE22082T1 (de) | 9-thiomaytansinoide, ihre herstellung und ihre verwendung. | |
| AR241705A1 (es) | Procedimiento para preparar compuestos de 1-¡(isoxazolil o furanil) alcoxi¿-4-(4,5-dihidrooxazolil o dihidro-4h-oxazinil)-2,6-disustituido fenilo. | |
| ATE92475T1 (de) | Verfahren zur herstellung von 4-benzoyl-5hydroxypyrazolen. | |
| KR850004483A (ko) | 치환된 2-피리딜메틸-티오 및 -설피닐 벤즈이미다졸의 제조방법 | |
| KR840000463A (ko) | 광학적으로 활성인 1-방향족 그룹으로 치환된-1- 알카논의 제조방법 | |
| KR850001755A (ko) | 디히드로 이미다조피롤로피리딘류의 제조방법 | |
| ES449096A1 (es) | Un procedimiento para la preparacion de 11-desoxi-16-ariloxi-omega-tetranorprostaglandinas. | |
| KR860003239A (ko) | 퀴놀론 카복실산 유도체의 제조방법 | |
| KR830003457A (ko) | 2-아미노-4-치환-5-티아졸 카복실린산 및 그것의 유도체 | |
| KR870005954A (ko) | 개선된 5-(2,5-디메틸페녹시)-2,2-디메틸펜탄산의 제조 방법 | |
| KR900017983A (ko) | 1,4-디히드로-4-옥소-퀴놀린-3-카르복실산 에스테르의 제조 중간체 | |
| KR840004422A (ko) | 사이프로헵타딘-3-카복실산의 에스테르 및 관련 화합물의 제조방법 | |
| KR850002965A (ko) | 치환된 펜옥시알칸카복실산 에스테르의 제조방법 | |
| HUP9902443A2 (hu) | Új eljárás fenilcsoporttal helyettesített 2(5H)-furanon származékok előállítására, intermedierek | |
| KR910011776A (ko) | 연체동물 구제성 2,4,5-트리브로모피롤-3-카르보니트릴 화합물들의 제조 방법 | |
| DK1265837T3 (da) | Fremgangsmåde til fremstilling af o-chlormethylbenzoesyrechlorider | |
| KR840008355A (ko) | 히단토인 유도체의 제조방법 | |
| ES453323A1 (es) | Procedimiento para preparar fenoxialquilamidas. | |
| KR910007920A (ko) | 3-아로일-2-옥스인돌-1-카복스아미드의 제조방법 | |
| KR830000686A (ko) | 디페닐 에테르 유도체의 제조방법 | |
| KR850004963A (ko) | 피리딘 카복실산 유도체의 제조방법 | |
| KR860008965A (ko) | 1,3-프로판디온 유도체를 제조하는 방법 | |
| KR830001252A (ko) | 4-아닐리노퀴나졸린 유도체의 제조방법 | |
| KR930019610A (ko) | 선택적 할로겐화 반응에 의한 할로게노페녹시 지방산 유도체의 제조방법 및 할로게노페녹시 지방산 유도체 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E701 | Decision to grant or registration of patent right |